Antifungal agents: chemotherapeutic targets and immunologic strategies
- 1 February 1996
- journal article
- review article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 40 (2) , 279-291
- https://doi.org/10.1128/aac.40.2.279
Abstract
No abstract availableThis publication has 100 references indexed in Scilit:
- Antibodies Elicited by a Cryptococcus neoformans-Tetanus Toxoid Conjugate Vaccine Have the Same Specificity as Those Elicited in InfectionThe Journal of Infectious Diseases, 1992
- Role of yeast in cancer researchCancer, 1992
- Impact of the changing epidemiology of fungal infections in the 1990sEuropean Journal of Clinical Microbiology & Infectious Diseases, 1992
- Chitinase and chitin synthase 1: counterbalancing activities in cell separation of Saccharomyces cerevisiaeJournal of General Microbiology, 1992
- Emergence ofCandida krusei infections after therapy of oropharyngeal candidiasis with fluconazoleEuropean Journal of Clinical Microbiology & Infectious Diseases, 1991
- Failure of fluconazole therapy inCandida krusei fungemiaEuropean Journal of Clinical Microbiology & Infectious Diseases, 1991
- Polyamine depletion and growth inhibition ofCryptococcus neoformans by α-difluoromethylornithine and cyclohexylamineMycopathologia, 1990
- The mechanism of antifungal action of (S)-2-amino-4-oxo-5-hydroxypentanoic acid, RI-331: The inhibition of homoserine dehydrogenase in Saccharomyces cerevisiaeBiochemical and Biophysical Research Communications, 1990
- Regulation of the mevalonate pathwayNature, 1990
- Biosynthesis of the Fungal Wall-Mechanisms and Implications The First Fleming LectureJournal of General Microbiology, 1977